Literature DB >> 15120648

Interleukin-20.

Wenfeng Xu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15120648     DOI： 10.1016/j.intimp.2004.01.006

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN： 1567-5769            Impact factor:   4.932


× No keyword cloud information.
  4 in total

1.  Interleukin-20 promotes migration of bladder cancer cells through extracellular signal-regulated kinase (ERK)-mediated MMP-9 protein expression leading to nuclear factor (NF-κB) activation by inducing the up-regulation of p21(WAF1) protein expression.

Authors:  Se-Jung Lee; Seok-Cheol Cho; Eo-Jin Lee; Sangtae Kim; Soo-Bok Lee; Jung-Hyurk Lim; Yung Hyun Choi; Wun-Jae Kim; Sung-Kwon Moon
Journal:  J Biol Chem       Date:  2012-12-27       Impact factor: 5.157

2.  Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome.

Authors:  Ann L Truelove; Taras K Oleksyk; Sadeep Shrestha; Chloe L Thio; James J Goedert; Sharyne M Donfield; Gregory D Kirk; David L Thomas; Stephen J O'Brien; Michael W Smith
Journal:  Int J Immunogenet       Date:  2008-06       Impact factor: 1.466

3.  Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.

Authors:  Se-Jung Lee; Eo-Jin Lee; Seon-Kyu Kim; Pildu Jeong; Young-Hwa Cho; Seok Joong Yun; Sangtae Kim; Gi-Young Kim; Yung Hyun Choi; Eun-Jong Cha; Wun-Jae Kim; Sung-Kwon Moon
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

4.  Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.

Authors:  Hee-Jin Ahn; Kwang-Soo Kim; Kyung-Won Shin; Kee-Hwan Lim; Jin-Ock Kim; Je-Yong Lee; Jiewan Kim; Ji-Hoon Park; Kyung-Min Yang; Kwang-Hyun Baek; Jeong-Jae Ko; Kyung-Soon Park
Journal:  Oncotarget       Date:  2015-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.